Biotech & Health

How to obtain FDA buy-in and unlock more funding for your health tech startup


High angle view of many yellow padlocks on yellow background. One of them is open.
Image Credits: Javier Zayas Photography (opens in a new window) / Getty Images

Ramakant Vempati


Data analyst and former Goldman Sachs executive, Ramakant Vempati is the co-founder of 2022 FDA breakthrough device Wysa, an AI-based digital companion for behavioral health.

Many years ago, oil from Chinese water snakes was successfully used to treat joint pain until peddlers made “snake oil” synonymous with fraud. Times have changed, but the medical industry continues to walk a fine line between optical illusions and real solutions.

Now, as venture capital funding within health tech has fallen 41.2% compared to the same time last year, it’s even more important for emerging technologies to present more than promises.

By reaching for the highest standards and obtaining regulatory certification from institutions like the U.S. Food and Drug Administration (FDA), startups can show investors and clients that they’ve gone through the necessary checks for safe use in healthcare, creating more opportunity to drive long-term success.

FDA breakthrough device designation

The influx of artificial intelligence in healthcare is exciting but often met with skepticism from the public, and rightfully so. The stakes for a poorly designed digital health product are higher than any other industry, and the costs of failure much more serious.

There are many regulatory organizations that offer credibility and validation to incoming healthcare solutions, but the FDA is the best place to start. Why? The large U.S. market and its reputation for a rigorous framework around approvals will make it easier to expand down the road. Also, the FDA is one of the few agencies that has created a distinct path for software as a medical device (SaMD) to gain approval.

The FDA’s breakthrough device program focuses on technology that will meaningfully help an overly taxed system. It’s an increasingly well-supported pathway that makes it easier for innovators to bring products to market faster, and it’s one of the best examples across the world of how regulators are responding to and working with innovators.

Devices must meet two criteria to be eligible for breakthrough device designation. First, the device must provide effective treatment or diagnosis of a life-threatening or irreversibly debilitating human disease or condition. Second, the device must meet at least one of the following: The device represents breakthrough technology; no approved or cleared alternatives exist; the device offers significant advantages over existing approved or cleared alternatives; and the device availability is in the best interest of patients.

While the FDA will give you an opportunity, it is up to your startup to test rigorously for efficacy and meet the highest standards when the time comes. The first criteria will be the most difficult bar to clear, as you must show clinical efficacy. The breakthrough device designation program is based on pilot studies done on the technology.

How to prove clinical efficacy

Recently, the Journal of Medical Internet Research analyzed over 224 venture-backed digital health startups that have raised more than $2 million in funding. The study rated each company on a scale of 0 to 10 for “clinical robustness,” 10 being the highest possible score. Of all the startups, 43.8% scored a zero. It’s no wonder venture capitalists are pulling back.

Startups hoping to secure regulatory buy-in from the FDA must test to ensure the device is more effective at treatment or diagnosis for a serious illness. This means testing not just for a device’s efficacy but conducting studies that compare it to existing, approved treatments.

The particular clinical trial that allowed Wysa to receive FDA Breakthrough Device designation (BDD) was done with Washington University in St. Louis and tested the app’s efficacy in reducing symptoms of depression and anxiety, which commonly co-exist with musculoskeletal chronic pain. The study had to prove that Wysa is more effective than standard orthopedic treatment.

How to request designation

Companies can send a breakthrough designation request to the FDA anytime before sending a marketing submission — during pre-market approval (PMA), pre-market notification (510(k)) or a De Novo Classification request. In some cases, the FDA might find a company and recommend they apply for the program, but it’s not necessary to wait.

After applying, it typically takes two months to receive the designation. Once granted, a company can work with the FDA in a variety of ways to continue development. One of the biggest benefits, besides investor relations, is that a breakthrough device will have priority review on future regulatory submissions, accelerating subsequent processes. It also positions the company as part of an elite group that is viewed as best-in-class by investors, in demand with partners and trusted by users.

After receiving the device designation, and undoubtedly helped by the way this signals quality around the world, Wysa has raised a Series B round, commissioned within the U.K. National Health Service (NHS) and has been invited to participate in clinical trials with leading research institutions.

Distribution of this designation grew steadily from 11 in 2015 to 206 in 2021, but it is a very challenging task to qualify, and the success rates are low. The specific areas of health that receive the largest number of breakthrough device designations are cardiovascular, neurology and orthopedic, followed by gastroenterology and urology, general and plastic surgery, and immunology. The least designated areas are obstetrics, dental and clinical toxicology. For additional insight, you can search the FDA’s website to see which companies are receiving designations.

The guidance for this designation and other certificates from the FDA can be complex, to say the least. The good news is you can call and talk to regulatory authorities directly if you need to; they actually want to help you. You can also hire experts who have worked directly with regulatory authorities. Consultants can help at the primer stage and provide key points around the guidance.

Beyond the FDA

In addition to the FDA, startups can work with many other organizations to certify compliance and further build investor and consumer trust. Some best-in-class examples include:

  • ISO: Institute an information security and privacy management system from the beginning to ensure your data protection program complies with ISO standards. Have an independent expert audit and certify the organization, systems and processes.
  • ORCHA: Involve this globally recognized digital app safety rating agency to independently review and rate your apps in terms of data protection, user experience, clinical safety and clinical efficacy.
  • NHS: Establish and comply with the clinical risk management standards recommended by the NHS to ensure an app meets clinical safety and hazard management standards.
  • Digital Technology Assessment Criteria (DTAC): This gives U.K.-based healthcare providers, patients and citizens the confidence that the digital health tools they use meet National Health Service (NHS) clinical safety, data protection, technical security, interoperability and usability and accessibility standards.
  • Cyber Essentials: Undertake independent cybersecurity audits by getting audited and certified by Cyber Essentials.

True success in this industry comes from proving that your technology performs as well as, if not better than, the current standard of care. Startups should view privacy, safety and clinical validation not as nice-to-haves but as key components of the user persona they are building for.

Adhere to privacy and transparency standards

New technologies must be built with current and future global privacy standards in mind. It will always be a company’s responsibility to make sure consumers are protected while using any new technology as a health benefit.

General Data Protection Regulation (GDPR) in the EU/U.K., and the California Consumer Privacy Act (CCPA) in the U.S. are some of the most robust privacy regulations existing today, but it’s not enough to know these — be alert for future standards coming down the pipe.

For example, the U.S. is working on a bipartisan American Data Privacy and Protection Act which, though based on CCPA, could have some unique policies that impact how software can be designed or sold.

Looking ahead

Regulatory agencies like the MHRA, BfARM and FDA have taken steps to establish clean and fast pathways for digital health apps or devices to become a part of the healthcare landscape. They incentivize digital health with adaptive regulatory frameworks and fast-track approvals for adherence to common global standards such as the ISO. This is allowing more digital health innovators to offer products through visible public health pathways.

Many countries are now working together to align on guidelines that companies can adhere to. For example, the International Medical Device Regulators Forum (IMDRF) is a group of volunteer medical device regulators from around the world who have come together to form a consensus on medical device regulation to help better address the challenges with SaMD. This group is worth keeping an eye on over the next 10 years and will likely play a growing role in digital health. Their opinions on guidance could become the standard in years to come, which will make it easy for developers to meet criteria across borders and leave the laborious and time-consuming processes of today in the past.

By thinking about complex issues and unique aspects of safety, efficacy and privacy right from the beginning, startups can build something that truly makes a difference, impressing investors along the way. Regulatory buy-in can be tough to apply for and even more difficult to achieve, but any digital health technology with these distinctions will have more success in their market.

The biggest mistake a startup can make is trying to take a shortcut through or around these agencies. Any loophole just means the product falls short of critical health frameworks, with much higher costs — for themselves and others — that make it harder for the technology to be adopted and actually help people. If you take this path, what you’re building may end up like snake oil.

More TechCrunch

Welcome back to TechCrunch’s Week in Review. This week had two major events from OpenAI and Google. OpenAI’s spring update event saw the reveal of its new model, GPT-4o, which…

OpenAI and Google lay out their competing AI visions

Expedia says Rathi Murthy and Sreenivas Rachamadugu, respectively its CTO and senior vice president of core services product & engineering, are no longer employed at the travel booking company. In…

Expedia says two execs dismissed after ‘violation of company policy’

When Jeffrey Wang posted to X asking if anyone wanted to go in on an order of fancy-but-affordable office nap pods, he didn’t expect the post to go viral.

With AI startups booming, nap pods and Silicon Valley hustle culture are back

OpenAI’s Superalignment team, responsible for developing ways to govern and steer “superintelligent” AI systems, was promised 20% of the company’s compute resources, according to a person from that team. But…

OpenAI created a team to control ‘superintelligent’ AI — then let it wither, source says

A new crop of early-stage startups — along with some recent VC investments — illustrates a niche emerging in the autonomous vehicle technology sector. Unlike the companies bringing robotaxis to…

VCs and the military are fueling self-driving startups that don’t need roads

When the founders of Sagetap, Sahil Khanna and Kevin Hughes, started working at early-stage enterprise software startups, they were surprised to find that the companies they worked at were trying…

Deal Dive: Sagetap looks to bring enterprise software sales into the 21st century

Keeping up with an industry as fast-moving as AI is a tall order. So until an AI can do it for you, here’s a handy roundup of recent stories in the world…

This Week in AI: OpenAI moves away from safety

After Apple loosened its App Store guidelines to permit game emulators, the retro game emulator Delta — an app 10 years in the making — hit the top of the…

Adobe comes after indie game emulator Delta for copying its logo

Meta is once again taking on its competitors by developing a feature that borrows concepts from others — in this case, BeReal and Snapchat. The company is developing a feature…

Meta’s latest experiment borrows from BeReal’s and Snapchat’s core ideas

Welcome to Startups Weekly! We’ve been drowning in AI news this week, with Google’s I/O setting the pace. And Elon Musk rages against the machine.

Startups Weekly: It’s the dawning of the age of AI — plus,  Musk is raging against the machine

IndieBio’s Bay Area incubator is about to debut its 15th cohort of biotech startups. We took special note of a few, which were making some major, bordering on ludicrous, claims…

IndieBio’s SF incubator lineup is making some wild biotech promises

YouTube TV has announced that its multiview feature for watching four streams at once is now available on Android phones and tablets. The Android launch comes two months after YouTube…

YouTube TV’s ‘multiview’ feature is now available on Android phones and tablets

Featured Article

Two Santa Cruz students uncover security bug that could let millions do their laundry for free

CSC ServiceWorks provides laundry machines to thousands of residential homes and universities, but the company ignored requests to fix a security bug.

2 days ago
Two Santa Cruz students uncover security bug that could let millions do their laundry for free

TechCrunch Disrupt 2024 is just around the corner, and the buzz is palpable. But what if we told you there’s a chance for you to not just attend, but also…

Harness the TechCrunch Effect: Host a Side Event at Disrupt 2024

Decks are all about telling a compelling story and Goodcarbon does a good job on that front. But there’s important information missing too.

Pitch Deck Teardown: Goodcarbon’s $5.5M seed deck

Slack is making it difficult for its customers if they want the company to stop using its data for model training.

Slack under attack over sneaky AI training policy

A Texas-based company that provides health insurance and benefit plans disclosed a data breach affecting almost 2.5 million people, some of whom had their Social Security number stolen. WebTPA said…

Healthcare company WebTPA discloses breach affecting 2.5 million people

Featured Article

Microsoft dodges UK antitrust scrutiny over its Mistral AI stake

Microsoft won’t be facing antitrust scrutiny in the U.K. over its recent investment into French AI startup Mistral AI.

2 days ago
Microsoft dodges UK antitrust scrutiny over its Mistral AI stake

Ember has partnered with HSBC in the U.K. so that the bank’s business customers can access Ember’s services from their online accounts.

Embedded finance is still trendy as accounting automation startup Ember partners with HSBC UK

Kudos uses AI to figure out consumer spending habits so it can then provide more personalized financial advice, like maximizing rewards and utilizing credit effectively.

Kudos lands $10M for an AI smart wallet that picks the best credit card for purchases

The EU’s warning comes after Microsoft failed to respond to a legally binding request for information that focused on its generative AI tools.

EU warns Microsoft it could be fined billions over missing GenAI risk info

The prospects for troubled banking-as-a-service startup Synapse have gone from bad to worse this week after a United States Trustee filed an emergency motion on Wednesday.  The trustee is asking…

A US Trustee wants troubled fintech Synapse to be liquidated via Chapter 7 bankruptcy, cites ‘gross mismanagement’

U.K.-based Seraphim Space is spinning up its 13th accelerator program, with nine participating companies working on a range of tech from propulsion to in-space manufacturing and space situational awareness. The…

Seraphim’s latest space accelerator welcomes nine companies

OpenAI has reached a deal with Reddit to use the social news site’s data for training AI models. In a blog post on OpenAI’s press relations site, the company said…

OpenAI inks deal to train AI on Reddit data

X users will now be able to discover posts from new Communities that are trending directly from an Explore tab within the section.

X pushes more users to Communities

For Mark Zuckerberg’s 40th birthday, his wife got him a photoshoot. Zuckerberg gives the camera a sly smile as he sits amid a carefully crafted re-creation of his childhood bedroom.…

Mark Zuckerberg’s makeover: Midlife crisis or carefully crafted rebrand?

Strava announced a slew of features, including AI to weed out leaderboard cheats, a new ‘family’ subscription plan, dark mode and more.

Strava taps AI to weed out leaderboard cheats, unveils ‘family’ plan, dark mode and more

We all fall down sometimes. Astronauts are no exception. You need to be in peak physical condition for space travel, but bulky space suits and lower gravity levels can be…

Astronauts fall over. Robotic limbs can help them back up.

Microsoft will launch its custom Cobalt 100 chips to customers as a public preview at its Build conference next week, TechCrunch has learned. In an analyst briefing ahead of Build,…

Microsoft’s custom Cobalt chips will come to Azure next week

What a wild week for transportation news! It was a smorgasbord of news that seemed to touch every sector and theme in transportation.

Tesla keeps cutting jobs and the feds probe Waymo